⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARGX News
argenx SE American Depositary Shares
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
globenewswire.com
ARGX
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
globenewswire.com
ARGX
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight
globenewswire.com
IMVT
ROIV
CART
NVS
MRK
REGN
UCB
JNJ
AMGN
ARGX
KYMR
CABA
BMY
BHVN
Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP
globenewswire.com
ARGX
eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency
businesswire.com
ARGX
argenx announces Annual General Meeting of Shareholders on May 6, 2026
globenewswire.com
ARGX
Sorcero Introduces Field Medical Excellence & Insights and Congress Intelligence Solutions to Accelerate Evidence-based Medical Affairs Strategies
prnewswire.com
AMGN
BIIB
ARGX
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Vyvgart (Argenx) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ARGX
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
globenewswire.com
ARGX